Galecto Inc

General ticker "GLTO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $6.2M

Galecto Inc does not follow the US Stock Market performance with the rate: -32.1%.

Estimated limits based on current volatility of 4.0%: low 4.56$, high 4.94$

Factors to consider:

  • Current price 38.4% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [7.66$, 24.18$]
  • 2024-12-30 to 2025-12-30 estimated range: [5.66$, 15.78$]

Financial Metrics affecting the GLTO estimates:

  • Negative: Non-GAAP EPS, $ of -1.45 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -69.04 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term GLTO quotes

Long-term GLTO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $52.23MM $61.21MM $39.91MM
Operating Income $-52.23MM $-61.21MM $-39.91MM
Non-Operating Income $0.47MM $-0.42MM $1.56MM
Interest Expense $0.00MM $0.42MM $0.00MM
R&D Expense $38.49MM $48.21MM $23.77MM
Income(Loss) $-51.75MM $-61.62MM $-38.35MM
Profit(Loss) $-51.75MM $-61.62MM $-38.35MM
Stockholders Equity $117.22MM $61.75MM $32.33MM
Inventory $7.30MM $2.25MM $0.00MM
Assets $122.22MM $73.19MM $38.23MM
Operating Cash Flow $-52.31MM $-42.93MM $-36.91MM
Capital expenditure $0.22MM $0.20MM $0.00MM
Investing Cash Flow $-48.05MM $12.38MM $22.33MM
Financing Cash Flow $0.00MM $0.51MM $2.88MM
Earnings Per Share* $-50.75 $-61.04 $-36.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.